Item 1. Interim Financial Statements.
GESHER I ACQUISITION CORP.
CONDENSED BALANCE SHEETS
| |
June 30, 2022 | | |
September 30, 2021 | |
| |
(unaudited) | | |
| |
Assets: | |
| | |
| |
Current assets: | |
| | |
| |
Cash | |
$ | 228,350 | | |
$ | - | |
Prepaid expenses | |
| 255,222 | | |
| - | |
Deferred offering costs | |
| - | | |
| 208,199 | |
Total current assets | |
| 483,572 | | |
| 208,199 | |
Prepaid expenses, non-current | |
| 54,802 | | |
| - | |
Marketable securities held in Trust Account | |
| 116,310,252 | | |
| - | |
Total assets | |
$ | 116,848,626 | | |
$ | 208,199 | |
| |
| | | |
| | |
Liabilities and Shareholders’ (Deficit) Equity | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accrued offering costs and expenses | |
$ | 1,018,922 | | |
| 22,318 | |
Promissory note – related party | |
| 1,014,945 | | |
| 175,827 | |
Due to related party | |
| 85,000 | | |
| - | |
Total current liabilities | |
| 2,118,867 | | |
| 198,145 | |
Deferred underwriting commissions | |
| 4,025,000 | | |
| - | |
Total liabilities | |
| 6,143,867 | | |
| 198,145 | |
| |
| | | |
| | |
Commitments and Contingencies (Note 6) | |
| | | |
| | |
Ordinary shares subject to possible redemption, 11,500,000 and 0 shares at June 30, 2022 and September 30, 2021, respectively. | |
| 116,310,252 | | |
| - | |
| |
| | | |
| | |
Shareholders’ (Deficit) Equity: | |
| | | |
| | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | |
| - | | |
| - | |
Ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 3,075,000 shares issued and outstanding (excluding 11,500,000 and 0 shares subject to possible redemption) at June 30, 2022 and September 30, 2021, respectively. | |
| 308 | | |
| 308 | |
Additional paid-in capital | |
| - | | |
| 24,692 | |
Accumulated deficit | |
| (5,605,801 | ) | |
| (14,946 | ) |
Total shareholders’ (deficit) equity | |
| (5,605,493 | ) | |
| 10,054 | |
Total Liabilities and Shareholders’ (Deficit) Equity | |
$ | 116,848,626 | | |
$ | 208,199 | |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
GESHER I ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
| |
Three Months Ended June 30, | | |
Three Months Ended June 30, | | |
Nine Months Ended June 30, | | |
For the Period from February 23, 2021 (inception) through June 30, | |
| |
2022 | | |
2021 | | |
2022 | | |
2021 | |
| |
| | |
| | |
| | |
| |
Formation and operating costs | |
$ | 1,665,239 | | |
$ | 240 | | |
$ | 2,589,291 | | |
$ | 7,067 | |
Loss from operations | |
| (1,665,239 | ) | |
| (240 | ) | |
| (2,589,291 | ) | |
| (7,067 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other income: | |
| | | |
| | | |
| | | |
| | |
Change in fair value of over-allotment units | |
| — | | |
| — | | |
| 44,550 | | |
| — | |
Interest income earned on Trust Account | |
| 147,531 | | |
| — | | |
| 160,252 | | |
| — | |
Total other income | |
| 147,531 | | |
| — | | |
| 204,802 | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (1,517,708 | ) | |
$ | (240 | ) | |
$ | (2,384,489 | ) | |
$ | (7,067 | ) |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption | |
| 11,500,000 | | |
| — | | |
| 10,919,414 | | |
| — | |
Basic and diluted net loss per ordinary share subject to possible redemption | |
$ | (0.10 | ) | |
$ | — | | |
$ | (0.17 | ) | |
$ | — | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, nonredeemable ordinary shares | |
| 3,075,000 | | |
| 2,700,000 | | |
| 3,048,901 | | |
| 2,700,000 | |
Basic and diluted net loss per nonredeemable ordinary share | |
$ | (0.10 | ) | |
$ | (0.00 | ) | |
$ | (0.17 | ) | |
$ | (0.00 | ) |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
GESHER I ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ (DEFICIT) EQUITY
FOR THE THREE AND NINE MONTHS ENDED JUNE 30,
2022
| |
Ordinary shares | | |
Additional Paid-in | | |
Accumulated | | |
Shareholders’ Equity | |
| |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
(Deficit) | |
Balance as of October 1, 2021 | |
| 3,075,000 | | |
$ | 308 | | |
$ | 24,692 | | |
$ | (14,946 | ) | |
$ | 10,054 | |
Proceeds allocated to Public Warrants | |
| - | | |
| - | | |
| 8,165,000 | | |
| - | | |
| 8,165,000 | |
Proceeds allocated to Private Placement Warrants | |
| - | | |
| - | | |
| 5,000,000 | | |
| - | | |
| 5,000,000 | |
Incentives to anchor investors and forward purchasers | |
| - | | |
| - | | |
| 4,073,565 | | |
| - | | |
| 4,073,565 | |
Offering costs allocated to warrants | |
| - | | |
| - | | |
| (956,456 | ) | |
| - | | |
| (956,456 | ) |
Re-measurement of redeemable shares to redemption value | |
| - | | |
| - | | |
| (16,306,801 | ) | |
| (3,048,576 | ) | |
| (19,355,377 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| (169,564 | ) | |
| (169,564 | ) |
Balance as of December 31, 2021 | |
| 3,075,000 | | |
| 308 | | |
| - | | |
| (3,233,086 | ) | |
| (3,232,778 | ) |
Re-measurement of redeemable shares to redemption value | |
| | | |
| | | |
| | | |
| (10,259 | ) | |
| (10,259 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| (697,217 | ) | |
| (697,217 | ) |
Balance as of March 31, 2022 | |
| 3,075,000 | | |
| 308 | | |
| - | | |
| (3,940,562 | ) | |
| (3,940,254 | ) |
Re-measurement of redeemable shares to redemption value | |
| | | |
| | | |
| | | |
| (147,531 | ) | |
| (147,531 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| (1,517,708 | ) | |
| (1,517,708 | ) |
Balance as of June 30, 2022 | |
| 3,075,000 | | |
$ | 308 | | |
$ | - | | |
$ | (5,605,801 | ) | |
$ | (5,605,493 | ) |
FOR THE THREE MONTHS
ENDED JUNE 30, 2021 AND FOR THE PERIOD FROM FEBRUARY 23, 2021
(INCEPTION) THROUGH JUNE 30, 2021
| |
Ordinary shares | | |
Additional Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Equity | |
Balance as of February 23, 2021 (inception) | |
| - | | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
Ordinary shares issued to Sponsor | |
| 2,875,000 | | |
| 288 | | |
| 24,712 | | |
| - | | |
| 25,000 | |
Issuance of representative shares | |
| 200,000 | | |
| 20 | | |
| (20 | ) | |
| - | | |
| - | |
Net loss | |
| - | | |
| - | | |
| - | | |
| (6,827 | ) | |
| (6,827 | ) |
Balance as of March 31, 2021 | |
| 3,075,000 | | |
| 308 | | |
| 24,692 | | |
| (6,827 | ) | |
| 18,173 | |
Net loss | |
| - | | |
| - | | |
| - | | |
| (240 | ) | |
| (240 | ) |
Balance as of June 30, 2021 | |
| 3,075,000 | | |
$ | 308 | | |
$ | 24,692 | | |
$ | (7,067 | ) | |
$ | 17,933 | |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
GESHER I ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
| |
Nine Months Ended June 30, | | |
For the Period from February 23, 2021 (Inception) through June 30, | |
| |
2022 | | |
2021 | |
Cash Flows from Operating Activities: | |
| | |
| |
Net loss | |
$ | (2,384,489 | ) | |
$ | (7,067 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
Formation costs paid by Sponsor in exchange for issuance of ordinary shares | |
| — | | |
| 6,827 | |
Formation costs paid by Sponsor loan | |
| — | | |
| 240 | |
Interest earned on marketable securities held in Trust Account | |
| (160,252 | ) | |
| — | |
Changes in current assets and liabilities: | |
| | | |
| | |
Prepaid assets | |
| (310,024 | ) | |
| — | |
Due to related party | |
| 85,000 | | |
| — | |
Accrued offering costs and expenses | |
| 996,604 | | |
| — | |
Net cash used in operating activities | |
| (1,773,161 | ) | |
| — | |
| |
| | | |
| | |
Cash Flows from Investing Activities: | |
| | | |
| | |
Principal deposited in Trust Account | |
| (116,150,000 | ) | |
| — | |
Net cash used in investing activities | |
| (116,150,000 | ) | |
| — | |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Proceeds from initial public offering, net of costs | |
| 112,655,450 | | |
| — | |
Proceeds from private placement | |
| 5,000,000 | | |
| — | |
Proceeds from issuance of related party loan | |
| 1,014,945 | | |
| — | |
Payment of promissory note to related party | |
| (182,127 | ) | |
| — | |
Payment of deferred offering costs | |
| (336,757 | ) | |
| — | |
Net cash provided by financing activities | |
| 118,151,511 | | |
| — | |
| |
| | | |
| | |
Net Change in Cash | |
| 228,350 | | |
| — | |
Cash – Beginning | |
| — | | |
| — | |
Cash – Ending | |
$ | 228,350 | | |
$ | — | |
| |
| | | |
| | |
Non-cash investing and financing activities: | |
| | | |
| | |
Deferred offering costs paid by Sponsor in exchange for issuance of ordinary shares | |
$ | — | | |
$ | 18,173 | |
Deferred underwriting commissions payable charged to additional paid in capital | |
$ | 4,025,000 | | |
$ | — | |
Deferred offering costs paid by Sponsor loan | |
$ | 6,300 | | |
$ | 105,020 | |
Incentives to anchor investors and forward purchasers | |
$ | 4,073,565 | | |
$ | — | |
Issuance of representative shares | |
$ | — | | |
$ | 20 | |
Re-measurement of Class A ordinary share subject to redemption | |
$ | 160,252 | | |
$ | — | |
The accompanying notes are an integral part of
these unaudited condensed financial statements.
GESHER I ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2022
Note 1—Organization and Business Operation
Gesher I Acquisition Corp. (the “Company”)
is a newly organized blank check company incorporated as a Cayman Islands exempted company on February 23, 2021. The Company was formed
for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business
combination with one or more businesses or entities (the “Business Combination”). On May 31, 2022, the Company entered into
a Business Combination Agreement (see Note 6).
As of June 30, 2022, the Company has neither engaged
in any operations nor generated any revenues. All activity for the period from February 23, 2021 (inception) through June 30, 2022 relates
to the Company’s formation and the initial public offering described below and searching for a Business Combination and in connection
therewith entered into the Business Combination Agreement. The Company will not generate any operating revenues until after the completion
of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on
cash and cash equivalents from the proceeds derived from the Initial Public Offering (the “IPO”).
On October 12, 2021, the Company changed its fiscal
year end from December 31 to September 30.
The Company’s sponsor is Gesher I Sponsor
LLC, a Delaware limited liability company (the “Sponsor”).
The registration statement for the Company’s
IPO was declared effective on October 12, 2021 (the “Effective Date”). On October 14, 2021, the Company’s consummated
the IPO of 10,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3 (the “IPO”),
generating gross proceeds to the Company of $100,000,000. Each Unit consists of one ordinary share (the “Public Shares”) and
one-half of one warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one ordinary share at
a price of $11.50 per share.
Simultaneously with the consummation of the IPO,
the Company consummated the private placement of 4,550,000 warrants (the “Private Placement Warrants”) at a price
of $1.00 per Private Placement Warrant in a private placement, generating gross proceeds to the Company of $4,550,000, which is described
in Note 4.
On October 20, 2021, the Company issued an additional
1,500,000 Units in connection with the full exercise by the underwriters of their over-allotment option, generating gross proceeds of
$15,000,000, which is discussed in Note 3. Simultaneously with the closing of the underwriters’ full exercise of the over-allotment
option, the Company sold an additional 450,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, in a private
placement (together with the Private Placement, the “Private Placements”) generating gross proceeds of $450,000, which is
discussed in Note 4.
Transaction costs amounted to $10,949,821 consisting
of $2,300,000 of underwriting commissions, $4,025,000 of deferred underwriting commissions, $4,073,565 of incentives to
Anchor Investors (see Note 3) and Forward Purchase Investors (see Note 6), and $551,256 of other offering costs.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially
all of the net proceeds are intended to be applied generally toward consummating a Business Combination.
The Company must complete one or more initial
Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account
(as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at
the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination
if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires
a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company
Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business
Combination successfully.
Following the closing of the IPO on October 14,
2021 and underwriters’ full exercise of their over-allotment option on October 20, 2021, $116,150,000 ($10.10 per Unit)
from the net proceeds of the sale of the Units and the sale of the Private Placement Warrants was deposited into a trust account (the
“Trust Account”), invested in United States “government securities” within the meaning of Section 2(a)(16) of
the Investment Company Act with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated
under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned
on the funds held in the Trust Account that may be released to the Company to pay its income or other tax obligations as described in
the IPO, the proceeds will not be released from the Trust Account until the earlier of the completion of a Business Combination or the
redemption of 100% of the outstanding public shares if the Company has not completed a Business Combination within the time required time
period.
The Company will either (1) give the shareholders
the opportunity to vote on the Business Combination or (2) provide the public shareholders with the opportunity to sell their ordinary
shares to the Company in a tender offer for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account,
less taxes.
All of the Public Shares contain a redemption
feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder
vote or tender offer in connection with the initial Business Combination and in connection with certain amendments to the Company’s
amended and restated memorandum and articles of association.
In accordance with Financial Accounting Standards
Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480-10-S99, redemption provisions not solely within
the control of a company require ordinary shares subject to redemption to be classified outside of permanent equity. Given that the Public
Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of ordinary shares classified
as temporary equity will be the allocated proceeds determined in accordance with FASB ASC 470-20. The Public Shares are subject to FASB
ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete
changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument
will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value
immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting
period. The Company has elected to recognize the changes immediately.
The ordinary shares subject to redemption were
recorded at redemption value and classified as temporary equity upon the completion of the IPO, in accordance with FASB ASC Topic 480
“Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company’s ordinary
shares are not considered a “penny stock” upon such consummation of a Business Combination and, if the Company seeks shareholder
approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.
The Company will have 18 months from the closing
of the IPO to complete the initial Business Combination. If the Company does not consummate an initial Business Combination within 18
months from the closing of the IPO (the “Combination Period”) and the Company’s shareholders do not amend the Certificate
of Incorporation to provide the Company with more time to consummate a Business Combination, the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100%
of the outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
including any interest not previously released to the Company but net of taxes payable (and less up to $50,000 of interest to pay liquidation
expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’
rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors,
dissolve and liquidate, subject (in the case of (ii) and (iii) above) to the Company’s obligations under Cayman Islands law to provide
for claims of creditors and the requirements of other applicable law.
The Sponsor has agreed (a) to waive its redemption
rights with respect to the founder shares and Public Shares held by it in connection with the completion of a Business Combination and
(b) not to propose an amendment to the amended and restated memorandum and articles of association that would affect a public shareholders’
ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of
the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless
the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
The Sponsor has agreed that it will be liable
to ensure that the proceeds in the Trust Account are not reduced below $10.10 per share by the claims of target businesses or claims
of vendors or other entities that are owed money by the Company for services rendered or contracted for or products sold to the Company.
The agreement entered into by the Sponsor specifically provides for two exceptions to the indemnity it has given: it will have no liability
(1) as to any claimed amounts owed to a target business or vendor or other entity who has executed an agreement with the Company waiving
any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, or (2) as to any claims for
indemnification by the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. The Company’s
independent registered public accounting firm, and the underwriters of the IPO, will not execute agreements with the Company waiving such
claims to the monies held in the Trust Account. The Company has not asked the Sponsor to reserve for such indemnification obligations,
nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes
that the Sponsor’s only assets are securities of the Company. Therefore, the Company believes it is unlikely that the Sponsor will
be able to satisfy its indemnification obligations if it is required to do so.
Liquidity and Going Concern
As of June 30, 2022, the Company had $228,350
in cash and working capital deficit of $1,635,295.
Prior to the completion of the Initial
Public Offering, the Company’s liquidity needs had been satisfied through a payment from the Sponsor of $25,000 (see Note
5) for the founder shares to cover certain offering costs, and the loan under an unsecured promissory note from the Sponsor of
$182,127 (see Note 5). The promissory note was paid in full on October 18, 2021. Subsequent to the consummation of the Initial
Public Offering and Private Placement, the Company’s liquidity needs have been satisfied through the proceeds from the
consummation of the Private Placement not held in the Trust Account and Working Capital Loans (as defined below in Note 5). As of
June 30, 2022, there were $1,014,945 outstanding under Working Capital Loans.
In connection with the Company’s assessment
of going concern considerations in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic
205-40, “Presentation of Financial Statements – Going Concern,” the Company has until April 14, 2023, to consummate
an initial business combination. It is uncertain that the Company will be able to consummate an initial business combination by this time.
If an initial business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of
the Company. Management has determined that the liquidity condition and the mandatory liquidation, should an initial business combination
not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern.
No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April
14, 2023.
Risks and Uncertainties
Management is currently evaluating the impact
of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s
financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial
statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.
Note 2—Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial
statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“US
GAAP”) for financial information and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (“SEC”).
Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, the unaudited
condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement
of the balances and results for the period presented. Operating results for the three and nine months ended June 30, 2022 are not necessarily
indicative of the results that may be expected through September 30, 2022.
The accompanying unaudited condensed financial
statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final
prospectus filed by the Company with the SEC on October 21, 2021 and October 13, 2021, respectively.
Emerging Growth Company Status
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s unaudited condensed financial statement with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of the unaudited condensed financial
statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the
reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is
at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date
of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term
due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of June 30, 2022 and September 30, 2021.
Marketable Securities Held in Trust Account
At June 30, 2022, the assets held in the Trust
Account were held in treasury funds. All of the Company’s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest income in the accompanying statements of operations.
The estimated fair value of investments held in Trust Account are determined using available market information.
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage of $250,000. At June 30, 2022 and September 30, 2021, the Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account.
Fair Value Measurements
Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement
date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and
the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
|
● |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
|
● |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
|
● |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
In some circumstances, the inputs used to measure
fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is
categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Ordinary Shares Subject to Possible Redemption
All of the 11,500,000 ordinary shares
sold as part of the Units contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s
liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain
amendments to the Company’s amended and restated memorandum and articles of association. In accordance with ASC 480-10-S99, redemption
provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent
equity. Therefore, all 11,500,000 ordinary shares were classified outside of permanent equity as of June 30, 2022.
The Company recognized changes in redemption value
immediately as they occur upon the IPO and will adjust the carrying value of redeemable ordinary shares to equal the redemption value
at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges
against additional paid in capital and accumulated deficit.
Offering Costs associated with the Initial
Public Offering
The Company complies with the requirements of
ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the IPO that
were directly related to the IPO. The Company incurred offering costs amounting to $10,949,821 as a result of the IPO consisting of $2,300,000
of underwriting commissions, $4,025,000 of deferred underwriting commissions, $4,073,565 of incentives to Anchor Investors (see Note 3)
and Forward Purchase Investors (see Note 6), and $551,256 of other offering costs.
Net Loss Per Ordinary Share
The Company has two categories of shares, which
are referred to as redeemable ordinary shares and non-redeemable ordinary shares. Earnings and losses are shared pro rata between the
two categories of shares. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted
net loss per share for each category:
|
|
Three Months Ended
June 30, 2022 |
|
|
Three Months Ended
June 30, 2021 |
|
|
Nine Months Ended
June 30, 2022 |
|
|
For the Period from
February 23, 2021
(Inception) Through
June 30, 2021 |
|
|
|
Redeemable |
|
|
Non-redeemable |
|
|
Redeemable |
|
|
Non-redeemable |
|
|
Redeemable |
|
|
Non-redeemable |
|
|
Redeemable |
|
|
Non-redeemable |
|
Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net loss |
|
$ |
(1,197,505 |
) |
|
$ |
(320,203 |
) |
|
$ |
— |
|
|
|
(240 |
) |
|
$ |
(1,864,020 |
) |
|
$ |
(520,469 |
) |
|
$ |
— |
|
|
$ |
(7,067 |
) |
Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding |
|
|
11,500,000 |
|
|
|
3,075,000 |
|
|
|
— |
|
|
|
2,700,000 |
|
|
|
10,919,414 |
|
|
|
3,048,901 |
|
|
|
— |
|
|
|
2,700,000 |
|
Basic and diluted net loss per share |
|
$ |
(0.10 |
) |
|
$ |
(0.10 |
) |
|
$ |
— |
|
|
|
— |
|
|
$ |
(0.17 |
) |
|
$ |
(0.17 |
) |
|
$ |
— |
|
|
$ |
— |
|
Derivative Financial Instruments
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic
815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative
instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in
the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified
in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument
could be required within 12 months of the balance sheet date. The Company has determined the warrants to be issued in the IPO meet
the requirements for equity classification.
Income Taxes
The Company accounts for income taxes under FASB
ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected
impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit
to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when
it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies the accounting for uncertainty
in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process
for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits
to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides
guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company is subject to potential Israeli income
tax and filing requirements due to its presence in Tel Aviv. Income of the Israeli company will be taxable at corporate tax rate of 23%.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, Debt-Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting
for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions
that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation
in certain areas. The Company adopted ASU 2020-06 on February 23, 2021. Adoption of the ASU did not impact the Company’s financial
statements.
Management does not believe that any other recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed
financial statement.
Note 3—Initial Public Offering
On October 14, 2021, the Company sold 10,000,000 Units
at a purchase price of $10.00 per Unit. Each Unit consists of one ordinary share and one-half of one warrant. Each whole warrant
entitles the holder to purchase one ordinary share at a price of $11.50 per share. Each warrant will become exercisable 30 days after
the completion of an initial Business Combination and will expire on the fifth anniversary of the completion of an initial Business Combination,
or earlier upon redemption or liquidation.
Following the closing of the IPO on October 14,
2021, $101,000,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement
Warrants was deposited into the Trust Account. The net proceeds deposited into the Trust Account are invested in United States “government
securities” within the meaning of Section 2(a)(16) of the Investment Company Act with a maturity of 180 days or less or in money
market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S.
government treasury obligations.
Prior to the IPO, five members of the Sponsor
and one institutional investor (collectively, the “Anchor Investors”) have each expressed an interest to purchase units in
the IPO at a level of up to and in no event exceeding 9.9% of the units subject to the IPO. As incentives for the Anchor Investors,
upon consummation of the IPO, the Sponsor transferred 50,000 founder shares, with an aggregate fair value of $339,500, to one
Anchor Investor for the same price originally paid for such shares. Five Anchor Investors received an aggregate of 250,000 membership
interests in the Sponsor, with an aggregate fair value of $1,697,500, for no consideration. The excess of the fair value of the founder
shares transferred over the original issuance price of $339,065 and the fair value of the membership interests transferred of $1,697,500 were
accounted for as offering costs with an offset to additional paid-in capital upon the IPO.
The Company granted the underwriters a 45-day
option from the date of the IPO to purchase up to an additional 1,500,000 Units to cover over-allotments. On October 20, 2021, the
underwriters exercised the over-allotment option in full to purchase 1,500,000 Units, at a purchase price of $10.00 per Unit,
generating gross proceeds to the Company of $15,000,000.
As of June 30, 2022 and December 31, 2021, the
ordinary shares reflected on the balance sheet are reconciled in the following table:
Gross proceeds from IPO | |
$ | 115,000,000 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
| (8,165,000 | ) |
Ordinary shares issuance costs | |
| (10,037,915 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 19,355,377 | |
Ordinary shares subject to redemption, as of December 31, 2021 | |
| 116,152,462 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 10,259 | |
Ordinary shares subject to redemption, as of March 31, 2022 | |
| 116,162,721 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 147,531 | |
Ordinary shares subject to redemption, as of June 30, 2022 | |
$ | 116,310,252 | |
Note 4—Private Placement
Simultaneously with the closing of the IPO, the
Sponsor and EarlyBirdCapital, Inc., the representative of the underwriters, purchased an aggregate of 4,550,000 Private Placement
Warrants, each exercisable to purchase one ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $4,550,000 in
the aggregate, in a private placement.
On October 20, 2021, simultaneous with the exercise
of the over-allotment option in full, the Sponsor and EarlyBirdCapital, Inc., purchased an aggregate of 450,000 additional Private
Placement Warrants, at a purchase price of $1.00 per warrant, generating gross proceeds to the Company of $450,000.
The Private Placement Warrants are identical to
the warrants included in the Units sold in the IPO.
Note 5—Related Party Transactions
Founder Shares
Effective February 23, 2021, the Company issued 2,875,000 ordinary
shares, par value $0.0001, to the Sponsor for $25,000, or approximately $0.009 per share, to cover certain offering costs. Up to 375,000 founder
shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised.
Simultaneously, the Company issued to EarlyBirdCapital, Inc. and its designees the 200,000 representative shares.
Upon consummation of the IPO, the Sponsor transferred 50,000 founder
shares, with an aggregate fair value of $339,500, to one Anchor Investor for the same price originally paid for such shares
(see Note 3). The excess of the fair value of the founder shares transferred over the original issuance price of $339,065 was accounted
for as an offering cost with an offset to additional paid-in capital upon the IPO.
On October 20, 2021, the underwriters exercised
the over-allotment option in full to purchase 1,500,000 Public Units. As a result, 375,000 founder shares were no
longer subject to forfeiture.
On the date of the IPO, the founder shares were
placed into an escrow account maintained in New York, New York by Continental Stock Transfer & Trust Company, acting as escrow agent.
Subject to certain limited exceptions, these shares will not be transferred, assigned, sold or released from escrow (subject to certain
limited exceptions set forth below) until 180 days following the date of the consummation of the initial Business Combination, or earlier,
if, subsequent to the initial Business Combination, the Company consummates a liquidation, merger, stock exchange or other similar transaction
which results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property.
The founder shares are identical to the ordinary
shares included in the Units being sold in the IPO. However, the initial shareholders and officers and directors have agreed (A) to vote
any shares owned by them in favor of any proposed Business Combination, (B) not to convert any shares in connection with a shareholder
vote to approve a proposed initial Business Combination or sell any shares to the Company in a tender offer in connection with a proposed
initial Business Combination and (C) that the founder shares will not participate in any liquidating distributions from the Trust Account
upon winding up if a Business Combination is not consummated.
Promissory Note—Related Party
On March 1, 2021, the Company entered into a promissory
note of an aggregate of $150,000. The loan was to be payable without interest on the earlier to occur of July 31, 2021, the consummation
of the IPO, or the abandonment of the IPO.
On August 9, 2021, the Company entered into
a Promissory Note Extension Agreement with the Sponsor to extend the maturity date of the promissory note from July 31, 2021 to November
30, 2021. The loans will be payable without interest on the earlier to occur of November 30, 2021, the consummation of the IPO, or
the abandonment of the IPO.
On September 20, 2021, the Company amended the
promissory note to increase the principal to $201,000.
The Company had borrowed $182,127 under such promissory
note upon IPO, which was paid in full on October 18, 2021.
Related Party Loans
In order to finance transaction costs in connection
with an intended initial Business Combination, the Sponsor, initial shareholders, officers, directors or their affiliates may, but are
not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company consummates an initial
Business Combination, the Company would repay such loaned amounts; provided that up to $1,500,000 of such loans may be convertible
into warrants of the post Business Combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would
be identical to the Private Placement Warrants. In the event that the initial Business Combination does not close, the Company may use
a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from the Trust Account would
be used for such repayment.
On March 15, 2022, the Company entered into a
promissory note agreement with the Sponsor in the amount of $450,000. The promissory note would either be repaid upon consummation of
a Business Combination, without interest, or, at the lender’s discretion, convertible into warrants of the post-Business Combination
entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. The conversion feature was
analyzed under ASC 470-20, “Debt with Conversion or Other Options”, the note did not include any premium or discounts. The
conversion option did not include elements that would require bifurcation under ASC 815-40, “Derivatives and Hedging.”
On March 18, 2022, the Company entered into a
promissory note agreement with the Sponsor in the amount of up to $64,945 for expenses paid by the Sponsor on behalf of the Company. As
of June 30, 2022, the expenses paid by Sponsor on behalf of the Company totaled $53,609. On May 10, 2022, the Company borrowed an additional
$11,336 under the promissory note. The promissory note would either be repaid upon consummation of a Business Combination, without interest,
or, at the lender’s discretion, convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant.
The warrants would be identical to the Private Placement Warrants. The conversion feature was analyzed under ASC 470-20, “Debt with
Conversion or Other Options”, the note did not include any premium or discounts. The conversion option did not include elements
that would require bifurcation under ASC 815-40, “Derivatives and Hedging.”
On May 3, 2022, the Company entered into a promissory
note agreement with the Sponsor in the amount of $250,000. The promissory note would either be repaid upon consummation of a Business
Combination, without interest, or, at the lender’s discretion, convertible into warrants of the post-Business Combination entity
at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. The conversion feature was analyzed
under ASC 470-20, “Debt with Conversion or Other Options”, the note did not include any premium or discounts. The conversion
option did not include elements that would require bifurcation under ASC 815-40, “Derivatives and Hedging.”
On June 6, 2022, the Company entered into a promissory
note agreement with the Sponsor in the amount of $250,000. The promissory note would either be repaid upon consummation of a Business
Combination, without interest, or, at the lender’s discretion, convertible into warrants of the post-Business Combination entity
at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. The conversion feature was analyzed
under ASC 470-20, “Debt with Conversion or Other Options”, the note did not include any premium or discounts. The conversion
option did not include elements that would require bifurcation under ASC 815-40, “Derivatives and Hedging.”
As of June 30, 2022 and September 30, 2021, the
Company had $1,014,945 and $175,827 borrowings under the Working Capital Loans, respectively.
Administrative Service Fee
An affiliate of the Company’s Chief Operating
Officer has agreed that, commencing on the effective date of the IPO through the earlier of the consummation of the initial Business Combination
or the liquidation of the Trust Account, it will make available to the Company certain general and administrative services, including
office space, utilities and administrative support, as the Company may require from time to time. The Company has agreed to pay $10,000 per
month for these services. For the three and nine months ended June 30, 2022, the Company has incurred $30,000 and $85,000 in fees
for these services, respectively. As of June 30, 2022 and September 30, 2021, the Company has accrued $85,000 and $0 of administrative
service fees, which is included in due to related party in the accompanying balance sheets, respectively. For the period from February
23, 2021 (inception) through June 30, 2021, the Company did not incur any fees for these services.
Note 6—Commitments and Contingencies
Registration Rights
The holders of the founder shares issued and outstanding
on the date of the IPO, as well as the holders of the representative shares, Private Placement Warrants and any warrants the Sponsor,
officers, directors or their affiliates may be issued in payment of Working Capital Loans made to the Company (and all underlying securities),
will be entitled to registration rights pursuant to an agreement signed on October 12, 2021. The holders of a majority of these securities
are entitled to make up to two demands that the Company registers such securities. The holders of the majority of the founder shares can
elect to exercise these registration rights at any time commencing three months prior to the date on which these ordinary shares are to
be released from escrow. The holders of a majority of the representative shares, Private Placement Warrants and warrants issued to the
Sponsor, officers, directors or their affiliates in payment of Working Capital Loans made to the Company (or underlying securities) can
elect to exercise these registration rights at any time after the Company consummates a Business Combination. Notwithstanding anything
to the contrary, EarlyBirdCapital, Inc. may only make a demand on one occasion and only during the five-year period beginning on the effective
date of the registration statement. In addition, the holders have certain “piggy-back” registration rights with respect to
registration statements filed subsequent to the consummation of a Business Combination; provided, however, that EarlyBirdCapital, Inc.
may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the registration
statement. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters a 45-day
option from the date of the IPO to purchase up to an additional 1,500,000 units to cover over-allotments, if any.
On October 14, 2021, the Company paid cash underwriting
commissions of 2.0% of the gross proceeds of the IPO, or $2,000,000.
The underwriters are entitled to a deferred underwriting
commission of 3.5% of the gross proceeds of the IPO, or $3,500,000, which will be paid from the funds held in the Trust Account upon
completion of the Company’s initial Business Combination subject to the terms of the underwriting agreement.
On October 20, 2021, the underwriters exercised
the over-allotment option in full to purchase 1,500,000 Public Units at a purchase price of $10.00 per Public Unit, generating
gross proceeds to the Company of $15,000,000 (see Note 3), and were, in aggregate, paid a fixed underwriting discount of $300,000.
Representative Shares
Effective February 23, 2021, the Company issued
to EarlyBirdCapital, Inc. and its designees the 200,000 representative shares. The holders of the representative shares have
agreed not to transfer, assign or sell any such shares without the Company’s prior consent until the completion of the initial Business
Combination. In addition, the holders of the representative shares have agreed (i) to waive their conversion rights (or right to participate
in any tender offer) with respect to such shares in connection with the completion of the initial Business Combination and (ii) to waive
their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the initial
Business Combination within the Combination Period.
The representative shares have been deemed compensation
by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the effectiveness of the registration
statement pursuant to Rule 5110(e)(1) of the FINRA Manual. Pursuant to FINRA Rule 5110(e)(1), these securities will not be sold during
the IPO or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call
transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following
the effective date of the registration statement or commencement of sales of the IPO, except to any underwriter and selected dealer participating
in the IPO and their bona fide officers or partners, provided that all securities so transferred remain subject to the lockup restriction
above for the remainder of the time period.
Forward Purchase Agreements
In connection with the consummation of the IPO,
the Company entered into contingent forward purchase agreements (the “FPAs”) with certain members of the Sponsor (the “Forward
Purchase Investors”), which provided for the purchase by the Forward Purchase Investors of an aggregate of up to 4,500,000 units
for total gross proceeds of up to $45,000,000. On March 23, 2022, M&G (ACS) Japan Equity Fund, as managed by M&G Investment Management
Limited, and the Company entered into an amended and restated FPA (the “M&G FPA”), pursuant to which the Company will
issue and sell to M&G, and M&G committed to purchase, an aggregate of 4,000,000 units of the Company (or at the Company’s
option, the ultimate parent company in a Business Combination), at a purchase price of $10.00 per forward purchase unit, or $40,000,000
in the aggregate. Additionally, pursuant to the M&G FPA, M&G agreed to provide up to $10,000,000 of committed capital to the Company
in the event that, as of immediately prior to the Closing (as defined below), certain minimum cash conditions are not met after taking
into account redemptions by the Company’s shareholders in connection with the Transaction (as defined below) and certain other investments.
In exchange for providing the backstop commitment, M&G will receive from the Company (i) an additional amount of ordinary shares in
the Company (or at the Company’s option, the ultimate parent company in a Business Combination) equal to the amount of the backstop
commitment drawn, divided by $10.00 (rounded to the nearest whole number), and (ii) 500,000 warrants of the Company (or at the Company’s
option, the ultimate parent company in a Business Combination). The closing of the M&G FPA will be on the same date and immediately
prior to, or simultaneously with, the closing of a Business Combination. These units will be purchased, subject to certain conditions,
in a private placement to close immediately prior to, or simultaneously with, the consummation of the Company’s Business Combination.
The Company accounted for the FPAs in accordance with the guidance contained in ASC 815-40. Such guidance provides that the FPAs meet
the criteria for equity treatment due to no circumstances under which the Company can be forced to net cash settle the FPAs.
As incentives for the FPAs, upon consummation
of the IPO, the Forward Purchase Investors received an aggregate of 300,000 membership interests in the Sponsor, with an aggregate
fair value of $2,037,000, for no consideration, which were accounted for as offering costs with an offset to additional paid-in capital
upon the IPO.
Other than M&G, the other Forward Purchase
Investors have elected not to exercise their forward purchase rights in connection with the Business Combination.
Backstop Subscription Agreement
On April 14, 2022, the Company entered into
a backstop subscription agreement with Composite Analysis Group, Inc. (“Composite”), pursuant to which Composite has agreed
to provide $10,000,000 of committed capital to the Company in the event that, as of immediately prior to the closing of an initial business
combination, certain minimum cash conditions are not met after taking into account redemptions by Company shareholders in connection with
the business combination and certain other investments. In exchange for providing the Backstop Commitment, the Company will issue and
sell to Composite (a) 1,000,000 ordinary shares of the Company at a purchase price of $10.00 per share, and (b) 100,000 warrants of the
Company.
The closing of the Composite backstop subscription
will be on the same date and immediately prior to, or simultaneously with, the closing of the Business Combination.
Business Combination Agreement
On May 31, 2022, the Company entered into a Business
Combination Agreement (the “Business Combination Agreement”) with Freightos Limited, a Cayman Islands exempted company limited
by shares (“Freightos”), Freightos Merger Sub I, a Cayman Islands exempted company limited by shares and a direct wholly
owned subsidiary of Freightos (“Merger Sub I”), and Freightos Merger Sub II, a Cayman Islands exempted company limited by
shares and a direct wholly owned subsidiary of Freightos (“Merger Sub II”), pursuant to which, among other transactions, on
the terms and subject to the conditions set forth therein, (i) Merger Sub I will merge with and into the Company (the “First
Merger”), with the Company surviving the First Merger as a wholly owned subsidiary of Freightos, and (ii) the Company will
merge with and into Merger Sub II (the “Second Merger” and together with the First Merger, collectively, the “Mergers”),
with Merger Sub II surviving the Second Merger as a wholly owned subsidiary of Freightos.
The Business Combination
Pursuant to the Business Combination Agreement, at the closing
(the “Closing”) of the transactions contemplated thereunder (collectively, the “Transaction”), among other things,
(i) each ordinary share of Gesher, par value $0.0001 per share (“Gesher Ordinary Shares”), issued and outstanding immediately
prior to the First Merger (and after giving effect to the Unit Separation (as defined below) and any redemptions), will no longer be outstanding
and will automatically be converted into the right of the holder thereof to receive one ordinary share of Freightos, par value $0.00001
per share (“Freightos Ordinary Shares”), and (ii) each issued and outstanding warrant of Gesher (“Gesher Warrants”)
will be assumed by Freightos and converted into a corresponding warrant exercisable for Freightos Ordinary Shares subject to substantially
the same terms and conditions applicable to the Gesher Warrants (“Freightos Warrants”).
Immediately prior to the First Merger, the Gesher Ordinary
Shares and the Gesher Warrants comprising each issued and outstanding unit of Gesher (“Gesher Unit”), consisting of one Gesher
Ordinary Share and one-half of one Gesher Warrant, will be automatically detached (the “Unit Separation”) and the
holder thereof will be deemed to hold one Gesher Ordinary Share and one-half of one Gesher Warrant. No fractional Gesher Warrants
will be issued in connection with the Unit Separation such that if a holder of such Gesher Units would be entitled to receive a fractional
Gesher Warrant upon such separation, the number of Gesher Warrants to be issued to such holder upon such separation will be rounded down
to the nearest whole number of Gesher Warrants.
Immediately prior to the First Merger, Freightos and its
shareholders will engage in a recapitalization of its outstanding equity securities (the “Recapitalization”) so that the only
outstanding equity securities of Freightos will be Freightos Ordinary Shares and certain options to acquire Freightos Ordinary Shares
that will remain outstanding following the Transaction. To effect the Recapitalization, (1) each preferred share of Freightos will
automatically convert into Freightos Ordinary Shares in accordance with the Freightos organizational documents, and (2) immediately
following such conversion, the Freightos Ordinary Shares will automatically convert into such number of Freightos Ordinary Shares equal
to the quotient obtained by dividing 39,000,000 by the sum of (A) the number of Freightos Ordinary Shares then issued and outstanding
(including as a result of the aforementioned conversion of each preferred share of Freightos) and (B) without duplication, the number
of Freightos Ordinary Shares issuable upon the exercise of all options to acquire Freightos Ordinary Shares that either have vested prior
to such time or are to vest pursuant to their terms on or prior to September 30, 2022. Following the Recapitalization, the Freightos
Ordinary Shares shall be valued at $10.00 per share such that the total value of all Freightos Ordinary Shares equals $390,000,000, taking
into account the options to acquire Freightos Ordinary Shares that either have vested prior to Closing or are to vest pursuant to their
terms on or prior to September 30, 2022.
The Business Combination Agreement does not provide for
any purchase price adjustments.
The Transaction has been unanimously approved by the boards
of directors of both Gesher and Freightos.
Representations and Warranties
The Business Combination Agreement contains representations
and warranties of Freightos and its subsidiaries, including Merger Sub I and Merger Sub II, that are customary for transactions of this
nature, including with respect to, among other things: (i) corporate organization; (ii) Freightos’ subsidiaries; (iii) capitalization
of Freightos and its subsidiaries; (iv) the authorization, performance and enforceability against Freightos of the Business Combination
Agreement and the requisite shareholder approval; (v) absence of conflicts, and governmental consents and filings; (vi) compliance
with laws, and the existence, effectiveness, and status of necessary licenses and permits; (vii) certain tax matters; (viii) financial
statements and absence of changes; (ix) litigation; (x) absence of undisclosed liabilities; (xi) material contracts; (xii) title
to and sufficiency of assets; (xiii) real property; (xiv) Freightos’ intellectual property and data protection; (xv) labor
relations and employee matters; (xvi) broker’s fees; (xvii) environmental matters; (xviii) insurance; (xix) related
party transactions; (xx) supplied information for the Registration Statement on Form F-4 pertaining to the Transaction
(the “Registration Statement”) and certain other filings; (xxi) foreign private issuer and emerging growth company status;
and (xxii) certain matters related to the PIPE Financing (as defined below).
The Business Combination Agreement contains representations
and warranties of Gesher that are customary for transactions of this nature, including with respect to, among other things: (i) corporate
organization; (ii) capitalization and voting rights; (iii) Gesher’s subsidiaries; (iv) the authorization, performance,
and enforceability against Gesher of the Business Combination Agreement; (v) governmental approvals; (vi) absence of conflicts;
(vii) tax matters; (viii) financial statements; (ix) absence of changes; (x) litigation; (xi) broker’s fees;
(xii) supplied information for the Registration Statement pertaining to the Transaction and certain other filings; (xiii) the
trust account; (xiv) investment company and emerging growth company status; (xv) business activities; (xvi) Nasdaq quotation;
(xvii) private placements; and (xviii) related party transactions.
The representations and warranties made in the Business
Combination Agreement terminate as of, and will not survive, the Closing. There are no indemnification rights for another party’s
breach of any representations and warranties.
Covenants
The Business Combination Agreement contains certain customary
covenants by each of the parties during the period between the signing of the Business Combination Agreement and the earlier of the Closing
or the termination of the Business Combination Agreement in accordance with its terms (the “Interim Period”), including those
relating to: (i) the provision of access to their officers, directors, properties, offices, books and records and similar information
by the parties; (ii) the operation of their respective businesses in the ordinary course of business; (iii) the provision of
financial statements by Freightos to Gesher; (iv) indemnification of directors and officers and the purchase of tail directors’
and officers’ liability insurance; (v) notice of certain events; (vi) financial statements; (vii) no trading; (viii) Freightos’
efforts to call a meeting of its shareholders to approve the Transaction and related actions; (ix) approval and adoption of an equity
plan of Freightos; (x) completion of a reorganization of Freightos’ subsidiaries; (xi) completion of the Recapitalization;
(xii) Freightos efforts to obtain approval for listing of the Freightos Ordinary Shares and Freightos Warrants with the Nasdaq Stock
Market LLC (“Nasdaq”) prior to the First Merger, (xiii) appointment of the post-Closing board of directors of Freightos;
(xiv) amendment of the Freightos organizational documents; (xv) certain filings with the United States Securities and Exchange
Commission (the “SEC”); (xvi) efforts to obtain all necessary antitrust approvals; (xvii) the preparation and filing
of the Registration Statement by Freightos to register the Freightos Ordinary Shares, the Freightos Warrants and the Freightos Ordinary
Shares underlying the Freightos Warrants; (xviii) support of transaction and lockup agreements; (xix) certain tax matters; (xx) shareholder
litigation; (xxi) termination of an investor rights agreement; (xxii) efforts to consummate the private placement, forward purchase
subscription and backstop arrangements with investors (as described further below, the “Subscriptions”); (xxiii) public announcements;
and (xxiv) use of trust account proceeds.
Each party to the Business Combination Agreement
also agreed during the Interim Period not to solicit, initiate or knowingly facilitate or assist the making, submission or announcement
of or intentionally encourage alternative competing transactions with respect to itself, to notify the others as promptly as practicable
(and in any event within two business days) in writing of the receipt of any bona fide inquiries, proposals or offers, requests for information
or requests relating to an alternative competing transaction or any requests for non-public information relating to such transaction,
and to keep the other party informed of the status of any such inquiries, proposals, offers or requests for information. The parties
are also required to cease and terminate discussions regarding alternative transactions that may have been occurring prior to the Interim
Period.
The parties to the Business Combination Agreement
have agreed that after completion of the Transaction, the board of directors of Freightos shall be comprised of one designee of each of
Gesher (Ezra Gardner, Chief Executive Officer of Gesher) and Freightos (Zvi Schreiber, Chief Executive Officer of Freightos), and up to
seven directors to be mutually agreed by Gesher and Freightos, each of whom must qualify as independent under the rules of the Nasdaq,
regardless of whether such rules are applicable to Freightos.
The covenants and agreements of the parties
contained in the Business Combination Agreement do not survive the Closing, except those covenants and agreements to be performed after
the Closing, which covenants and agreement will survive until fully performed. There are no indemnification rights for another party’s
breach of any covenants.
Conditions to Closing
The Business Combination Agreement contains
customary conditions to Closing, including, among other things: (i) receipt of the required approval by the Gesher shareholders;
(ii) receipt of the required approval by the Freightos shareholders; (iii) receipt of required regulatory approvals, if any;
(iv) the absence of any law or governmental order prohibiting or making illegal the consummation of the Transaction; (v) Gesher
having at least $5,000,001 of net tangible assets immediately prior to Closing, or upon the consummation thereof; (vi) effectiveness
of the Registration Statement; (vii) the approval for listing of Freightos Ordinary Shares, Freightos Warrants, and the Freightos
Ordinary Shares underlying Freightos Warrants to be issued in connection with the Transaction on the Nasdaq, subject only to official
notice of issuance thereof; and (viii) completion of the Recapitalization in accordance with the terms of the Business Combination
Agreement and Freightos’ organizational documents.
The obligations of Freightos, Merger Sub I
and Merger Sub II to consummate the Transaction are also conditioned upon, among other things: (i) the accuracy of the representations
and warranties of Gesher (subject to certain materiality standards set forth in the Business Combination Agreement); (ii) material compliance
by Gesher with its pre-Closing covenants; (iii) the absence of any continuing event that has had, or would reasonably be
expected to have, individually or in the aggregate, a material adverse effect (a “Gesher Material Adverse Effect”) on (x) the
business, assets and liabilities, results of operations or financial condition of Gesher, or (y) Gesher’s ability to consummate
the Transaction, subject to customary exceptions; (iv) the funds contained in Gesher’s trust account (after giving effect to
the Gesher shareholder redemption), together with the aggregate amount of proceeds from any Subscriptions, equaling or exceeding $80,000,000;
and (v) delivery of certain Closing deliverables.
The obligations of Gesher to consummate the
Transaction is also conditioned upon, among other things: (i) the accuracy of the representations and warranties of Freightos, Merger
Sub I and Merger Sub II (subject to certain materiality standards set forth in the Business Combination Agreement); (ii) material compliance
by Freightos, Merger Sub I and Merger Sub II with their respective pre-Closing covenants; (iii) the absence of any continuing
event that has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect (a “Freightos
Material Adverse Effect”) on (x) the business, assets and liabilities of Freightos and its subsidiaries (taken as a whole)
or the results of operations or financial condition of Freightos and its subsidiaries (taken as a whole), subject to customary exceptions;
or (y) the ability of Freightos and its subsidiaries to consummate the Transaction; (iv) delivery of certain Closing deliverables;
and (v) completion of a reorganization of Freightos’ subsidiaries.
Termination
The Business Combination Agreement may be
terminated under certain customary and limited circumstances at any time prior to the Closing, including: (i) by mutual written consent
of Gesher and Freightos; (ii) by either Gesher or Freightos if a governmental authority has issued an order or taken any other action
that has the effect of making the Closing illegal or otherwise preventing or prohibiting the Transaction, and such order or other action
has become final and non-appealable; (iii) by Freightos if Gesher holds a meeting of its shareholders to approve the Business
Combination Agreement and the related transactions and such approval is not obtained; (iv) by Gesher if Freightos holds a meeting
of its shareholders to approve the Business Combination Agreement and related transactions and such approval is not obtained; (v) in
the event of the other party’s uncured breach, if such breach would result in the failure of the related Closing condition (and
so long as the terminating party is not in material breach of any of its representations, warranties, covenants or agreements under the
Business Combination Agreement); (vi) by either Gesher or Freightos if the Closing has not occurred by February 28, 2023, as long
as the terminating party’s breach did not cause or result in the failure of the Transaction to close by such date; (vii) by
Gesher if there has been a Freightos Material Adverse Effect following the date of the Business Combination Agreement that is continuing;
and (viii) by Freightos if there has been a Gesher Material Adverse Effect following the date of the Business Combination Agreement
that is continuing.
If the Business Combination Agreement is terminated,
all further obligations of the parties under the Business Combination Agreement (except for certain obligations related fees and expenses,
trust fund waiver, no recourse, termination and general provisions) will terminate, and no party to the Business Combination Agreement
will have any further liability to any other party thereto except for liability for fraud prior to termination. The Business Combination
Agreement does not provide for any termination fees.
Trust Account Waiver
Freightos, Merger Sub I and Merger Sub II
each agreed that they and their affiliates waived any past, present or future claim of any kind arising out of the Business Combination
Agreement against, and any right to access, the trust account for any monies that may be owed to them by Gesher or any of its affiliates
for any reason whatsoever.
Governing Law
The Business Combination Agreement is governed
by the laws of the State of Delaware; provided, that the statutory and fiduciary duties of the Freightos board of directors, the Gesher
board of directors, and the sole director of each of Merger Sub I and Merger Sub II, and the Mergers shall in each case be governed by
the laws of the Cayman Islands. The parties are subject to exclusive jurisdiction of the Delaware Court of Chancery and any state appellate
court therefrom within the State of Delaware, unless the Delaware Court of Chancery declines to accept jurisdiction over a particular
matter, in which case, in any federal court within the State of Delaware.
PIPE Financing
Concurrently with the execution of the Business Combination
Agreement, the Company, Freightos and Alshaffafia Trading W.L.L (the “PIPE Investor”), an affiliate of Qatar Airways Group
Q.C.S.C. (“Qatar Airways”), entered into a PIPE Subscription Agreement (the “PIPE Agreement”) pursuant to which
the PIPE Investor committed to purchase 1,000,000 Freightos Ordinary Shares at $10.00 per share for an aggregate purchase price of $10,000,000
(the “PIPE Financing”) immediately prior to the Closing. Each of the PIPE Investor and Qatar Airways are shareholders of Freightos.
Under the PIPE Agreement the obligations of the parties to consummate the PIPE Financing are subject to the satisfaction or waiver of
certain customary closing conditions of the respective parties, including, among others, (i) all conditions precedent under the Business
Combination Agreement having been satisfied or waived, (ii) the accuracy of representations and warranties of Freightos and the Company
in the Business Combination Agreement, (iii) Freightos material compliance with covenants and agreements in the PIPE Agreement, (iv) the
absence of a legal prohibition on consummating the PIPE Financing, and (v) the approval for listing of Freightos Ordinary Shares
on Nasdaq.
Support Agreements
Simultaneously with the execution and delivery of the Business
Combination Agreement, Gesher and Freightos entered into Support Agreements (collectively, the “Support Agreements”) with
certain shareholders of Freightos (the “Freightos Supporting Shareholders”). Pursuant to the Support Agreements, each Freightos
Supporting Shareholder agreed to vote all of such shareholder’s Freightos shares in favor of the Business Combination Agreement
and any actions that Freightos proposes in connection with the Transaction and to vote its Freightos shares against any other business
combination transaction, any material change in the capitalization or corporate structure of Freightos, or any other action or proposal
that would reasonably be expected to prevent, delay or adversely affect the Transaction. The Support Agreements prevent transfers of the
Freightos shares held by the Freightos Supporting Shareholders between the date of the Support Agreement and the Closing, except for certain
permitted transfers where the recipients also agree to comply with the Support Agreement.
Lock-Up Agreements
Simultaneously with the execution and delivery
of the Business Combination Agreement, certain members of the Sponsor (the “Sponsor Holders”) entered into a Lock-Up Agreement
with Freightos, the Company and Sponsor (collectively, the “Sponsor Lock-Up Agreements”). Pursuant to the Sponsor Lock-Up
Agreements, each Sponsor Holder agreed not to sell, hypothecate, pledge, hedge, grant any option to purchase or otherwise dispose of,
directly or indirectly, establish or increase certain derivative provisions with respect to the Restricted Securities (as defined below),
or transfer economic ownership of the Restricted Securities, or make a public announcement of the intention to effect any such transaction
(collectively, “Transfer”) any Freightos Ordinary Shares, Freightos Warrants, or any Freightos Ordinary Shares issuable in
respect of Freightos Warrants (collectively, the “Restricted Securities”) received by Sponsor and attributable to such Sponsor
Holder, from and after the Closing until the 36 month anniversary (such period, the “Sponsor Lock-Up Period”) of the date
on which Closing occurs (the “Sponsor Lock-Up Restrictions”). However, (i) at each nine month anniversary of the Closing
date, 25% of the Restricted Securities attributable to each Sponsor Holder will cease to be deemed Restricted Securities and (ii) if
prior to the end of the Sponsor Lock-Up Period, a Change of Control (as defined in the Sponsor Lock-Up Agreements) of Freightos occurs,
then all of the then-Restricted Securities will cease to be deemed Restricted Securities. When Restricted Securities cease to be Restricted
Securities, such released securities may be Transferred without regard to the Sponsor Lock-Up Restrictions.
Note 7—Shareholders’ (Deficit)
Equity
Preference shares—The Company is authorized
to issue 1,000,000 preference shares with a par value of $0.0001 per share and with such designations, voting and other
rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2022 and
September 30, 2021, there were no preference shares issued or outstanding.
Ordinary shares—The Company is authorized
to issue 100,000,000 ordinary shares with a par value of $0.0001 per share. As of June 30, 2022, there were 3,075,000 ordinary
shares issued and outstanding. As of September 30, 2021, there were no ordinary shares issued and outstanding.
Warrants—Each whole warrant entitles the
holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition,
if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing
of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue
price or effective issue price to be determined in good faith by the board of directors, and in the case of any such issuance to the Sponsor,
initial shareholders or their affiliates, without taking into account any founder shares held by them prior to such issuance), (y) the
aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for
the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions),
and (z) the volume weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day
prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below
$9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the
Market Value or (ii) the price at which the Company issues the additional ordinary shares or equity-linked securities.
The warrants will become exercisable 30 days after
the completion of an initial Business Combination. The warrants will expire at 5:00 p.m., New York City time, on the fifth anniversary
of the completion of an initial Business Combination, or earlier upon redemption.
No warrants will be exercisable for cash unless
the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the warrants and
a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the ordinary
shares issuable upon exercise of the warrants is not effective within a specified period following the consummation of the initial Business
Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company
shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided
by Section 3(a)(9) of the Securities Act of 1933, as amended, or the Securities Act, provided that such exemption is available. If that
exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.
The Company may redeem the outstanding warrants
in whole and not in part, at a price of $0.01 per warrant at any time after the warrants become exercisable, upon a minimum of 30
days’ prior written notice of redemption, if, and only if, the last sales price of the ordinary shares equals or exceeds $18.00 per
share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within a 30 trading
day period commencing at any time after the warrants become exercisable and ending three business days before the Company sends the notice
of redemption; and if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying
such warrants. If the foregoing conditions are satisfied and the Company issues a notice of redemption, each warrant holder can exercise
his, her or its warrant prior to the scheduled redemption date. However, the price of the ordinary shares may fall below the $18.00 trigger
price as well as the $11.50 warrant exercise price after the redemption notice is issued.
If the Company calls the warrants for redemption
as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so
on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the warrants for that number
of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants,
multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y)
the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the ordinary
shares for the five trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders
of warrants.
The Company accounted for the 10,750,000 warrants
issued in connection with the IPO (including the 5,750,000 Public Warrants included in the Units and the 5,000,000 Private
Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that the warrants meet the criteria
for equity treatment due to the existence of provisions whereby adjustments to the exercise price of the warrants is based on a variable
that is an input to the fair value of a “fixed-for-fixed” option and no circumstances under which the Company can be forced
to net cash settle the warrants.
The Company established the non-recurring fair
value for the Public Warrants of $8,165,000 on October 14, 2021, the date of the Company’s Initial Public Offering, using the
Monte Carlo Simulation. The Monte Carol Simulation is considered a Level 3 measurement.
The key inputs into the Monte Carlo Simulation
for the Public Warrants as of October 14, 2021, were as follows:
| |
October 14, | |
| |
2021 | |
Exercise price | |
$ | 11.50 | |
Stock price | |
$ | 9.26 | |
Volatility | |
| 30.0 | % |
Term | |
| 5.00 | |
Risk-free rate | |
| 0.93 | % |
Dividend yield | |
| 0.0 | % |
Significant increases (decreases) in the expected volatility in isolation
would result in a significantly higher (lower) fair value measurement.
Note 8—Fair Value Measurements
The following table presents information about
the Company’s assets that are measured at fair value on June 30, 2022, and indicates the fair value hierarchy of the valuation inputs
the Company utilized to determine such fair value:
| |
June 30, 2022 | | |
Quoted Prices In Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Marketable securities held in Trust Account | |
$ | 116,310,252 | | |
$ | 116,310,252 | | |
$ | — | | |
$ | — | |
| |
$ | 116,310,252 | | |
$ | 116,310,252 | | |
$ | — | | |
$ | — | |
The over-allotment option was accounted for as
liabilities in accordance with ASC 815-40 and is presented within liabilities on the balance sheets. The over-allotment liability is measured
at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of over-allotment
liability in the statements of operations.
The Company used a Black Scholes model to value
the over-allotment option. The over-allotment option was classified within Level 3 of the fair value hierarchy at the measurement dates
due to the use of unobservable inputs. Inherent in pricing models are assumptions related to expected share-price volatility, expected
life and risk-free interest rate. The Company estimates the volatility of its ordinary shares based on historical volatility that matches
the expected remaining life of the option. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant
date for a maturity similar to the expected remaining life of the option. The expected life of the option is assumed to be equivalent
to their remaining contractual term.
The key inputs into the Black Scholes model for
the over-allotment liability was as follows at initial measurement:
Input | |
October 14, 2021 | |
Risk-free interest rate | |
| 0.04 | % |
Expected term (years) | |
| 0.12 | |
Expected volatility | |
| 5.0 | % |
Exercise price | |
$ | 10.00 | |
Unit price | |
$ | 10.00 | |
Input | |
October 20, 2021 | |
Risk-free interest rate | |
| 0.04 | % |
Expected term (years) | |
| 0.11 | |
Expected volatility | |
| 5.0 | % |
Exercise price | |
$ | 10.00 | |
Unit price | |
$ | 10.00 | |
The following table sets forth a summary of the
changes in the fair value of the Level 3 over-allotment liability for the nine months ended June 30, 2022:
| |
Over-allotment
Liability | |
Fair value as of October 1, 2021 | |
$ | - | |
Initial fair value of over-allotment liability upon issuance at IPO | |
| 105,450 | |
Change in fair value | |
| (44,550 | ) |
Charged to shareholders’ (deficit) equity upon exercise | |
| (60,900 | ) |
Fair value as of June 30, 2022 | |
$ | — | |
Note 9—Subsequent Events
The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date the condensed financial statements were issued. Based upon this evaluation,
other than the below, the Company did not identify any other subsequent events that would have required adjustments or disclosure in the
condensed financial statements.